{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:15:38Z","timestamp":1769631338953,"version":"3.49.0"},"reference-count":31,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,12,1]]},"abstract":"<jats:p>BACKGROUND. We conducted a prospective, randomized, single-masked pilot study with the principal aim of comparing efficacy and tolerance between oral and intravenous ibuprofen in early closure of patent ductus arteriosus in very low birth weight infants. The possibility of ductal closure with only 1 or 2 doses of treatment was a secondary objective.<\/jats:p><jats:p>MATERIAL AND METHODS. Sixty-four very low birth weight patients with echocardiographically confirmed patent ductus arteriosus and respiratory distress were studied. The patients were randomly assigned to receive either oral (group O, n = 32) or intravenous (group I, n = 32) ibuprofen starting on the third day of life. After the first dose of treatment in both groups, echocardiographic evaluation was performed to determine the need for a second or third dose. The rate of ductal closure, adverse effects, complications, and the patient's clinical course were recorded.<\/jats:p><jats:p>RESULTS. In each group, 24 (75%) patients were born after 28 weeks' gestation. The rate of ductal closure tended to increase in group O (84.3% vs 62.5%). Closure of the ductus was obtained after 1 or 2 doses of treatment in 19 (70.3%) of 27 patients in group O and 14 (70%) of 20 patients in group I. The adverse effects were increased in group I (31.2% vs 9.3%). There were no significant differences with respect to complications during the stay. Adverse effects were significantly fewer when closure was achieved after an incomplete course of treatment (23.1% vs 76.9%).<\/jats:p><jats:p>CONCLUSIONS. In very low birth weight infants, the rate of early ductal closure with oral ibuprofen is at least as good as with the intravenous route. Ductal closure may be obtained with an incomplete course of ibuprofen. Oral ibuprofen is associated with fewer adverse effects. However, a larger sample is needed for more definitive conclusions.<\/jats:p>","DOI":"10.1542\/peds.2008-1780","type":"journal-article","created":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T14:23:01Z","timestamp":1228141381000},"page":"e1256-e1261","source":"Crossref","is-referenced-by-count":54,"title":["Randomized Pilot Study Comparing Oral Ibuprofen With Intravenous Ibuprofen in Very Low Birth Weight Infants With Patent Ductus Arteriosus"],"prefix":"10.1542","volume":"122","author":[{"given":"Ahmed","family":"Cherif","sequence":"first","affiliation":[{"name":"Neonatal Intensive Care Unit, Neonatology and Maternity Center, Faculty of Medicine, Department of Neonatology, University of Tunis, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naima","family":"Khrouf","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Neonatology and Maternity Center, Faculty of Medicine, Department of Neonatology, University of Tunis, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sami","family":"Jabnoun","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Neonatology and Maternity Center, Faculty of Medicine, Department of Neonatology, University of Tunis, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chahnez","family":"Mokrani","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Neonatology and Maternity Center, Faculty of Medicine, Department of Neonatology, University of Tunis, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moez Ben","family":"Amara","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Neonatology and Maternity Center, Faculty of Medicine, Department of Neonatology, University of Tunis, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nedia","family":"Guellouze","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Neonatology and Maternity Center, Faculty of Medicine, Department of Neonatology, University of Tunis, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samia","family":"Kacem","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Neonatology and Maternity Center, Faculty of Medicine, Department of Neonatology, University of Tunis, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2008,12,1]]},"reference":[{"key":"2021120822314703500_R1","doi-asserted-by":"crossref","unstructured":"The Vermont-Oxford Trials Network. Very low birth weight outcomes for 1990. Pediatrics.\u20081993;91(3):540\u2013545","DOI":"10.1542\/peds.91.3.540"},{"key":"2021120822314703500_R2","doi-asserted-by":"crossref","unstructured":"Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr.\u20081983;102(6):895\u2013906","DOI":"10.1016\/S0022-3476(83)80022-5"},{"key":"2021120822314703500_R3","doi-asserted-by":"crossref","unstructured":"Cotton RB, Stahlman MT, Bender HW, Graham TP, Catterton WZ, Kovar I. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr.\u20081978;93(4):647\u2013651","DOI":"10.1016\/S0022-3476(78)80910-X"},{"key":"2021120822314703500_R4","doi-asserted-by":"crossref","unstructured":"Weir FJ, Ohlsson A, Myhr TL, Fong K, Ryan ML. A patent ductus arteriosus is associated with reduced middle cerebral artery blood flow velocity. Eur J Pediatr.\u20081999;158(6):484\u2013487","DOI":"10.1007\/s004310051125"},{"key":"2021120822314703500_R5","doi-asserted-by":"crossref","unstructured":"Cherif A, Jabnoun S, Khrouf N. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants. Am J Perinatol.\u20082007;24(6):339\u2013345","DOI":"10.1055\/s-2007-981853"},{"key":"2021120822314703500_R6","doi-asserted-by":"crossref","unstructured":"Van Overmeire B, Smets K, Lecoutere D, et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med.\u20082000;343(10):674\u2013681","DOI":"10.1056\/NEJM200009073431001"},{"key":"2021120822314703500_R7","doi-asserted-by":"crossref","unstructured":"Papile LS, Burstein J, Burstein R, Koffler H. Incidence and evolution of the subependymal intraventricular hemorrhage: a study of infants weighing less than 1500 grams. J Pediatr.\u20081978;92(4):529\u2013534","DOI":"10.1016\/S0022-3476(78)80282-0"},{"key":"2021120822314703500_R8","doi-asserted-by":"crossref","unstructured":"de Vries LS, Eken P, Dubowitz LM. The spectrum of leukomalacia using cranial ultrasound. Behav Brain Res.\u20081992;49(1):1\u20136","DOI":"10.1016\/S0166-4328(05)80189-5"},{"key":"2021120822314703500_R9","doi-asserted-by":"crossref","unstructured":"Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis: therapeutic decisions based on clinical staging. Ann Surg.\u20081978;187(1):1\u20137","DOI":"10.1097\/00000658-197801000-00001"},{"key":"2021120822314703500_R10","doi-asserted-by":"crossref","unstructured":"Bancalari E. Changes in the pathogenesis and prevention of chronic lung disease of prematurity. Am J Perinatol.\u20082001;18(1):1\u20139","DOI":"10.1055\/s-2001-12940"},{"key":"2021120822314703500_R11","doi-asserted-by":"crossref","unstructured":"Lago P, Bettiol T, Salvadori S, et al. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. Eur J Pediatr.\u20082002;161(4):202\u2013207","DOI":"10.1007\/s00431-002-0915-y"},{"key":"2021120822314703500_R12","unstructured":"Hariprasad P, Sundarrajan V, Srimathy G, Suthager B, Ramadevi BS. Oral ibuprofen for closure of hemodynamically significant PDA in premature neonates. Indian Pediatr.\u20082002;39(1):99\u2013100"},{"key":"2021120822314703500_R13","unstructured":"Supapannachart S, Limrungsikul A, Khowsathit P. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital. J Med Assoc Thai.\u20082002;85(suppl 4):S1252\u2013S1258"},{"key":"2021120822314703500_R14","doi-asserted-by":"crossref","unstructured":"Aly H, Lotfy W, Badrawi N, Ghawas M, Abdel-Meguid IE, Hammad TA. Oral ibuprofen and ductus arteriosus in premature infants: a randomized pilot study. Am J Perinatol.\u20082007;24(5):267\u2013270","DOI":"10.1055\/s-2007-976550"},{"key":"2021120822314703500_R15","unstructured":"Chotigeat U, Jirapapa K, Layangkool T. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants. J Med Assoc Thai.\u20082003;86(suppl 3):S563\u2013S569"},{"key":"2021120822314703500_R16","unstructured":"Fakhraee SH, Badiee Z, Mojtahedzadeh S, Kazemian M, Kelishad R. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Zhongguo Dang Dai Er Ke Za Zhi.\u20082007;9(5):399\u2013403"},{"key":"2021120822314703500_R17","doi-asserted-by":"crossref","unstructured":"Heyman E, Morag I, Batash D, Keidar R, Baram S, Berkovitch M. Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study. Pediatrics.\u20082003;112(5). Available at: www.pediatrics.org\/cgi\/content\/full\/112\/5\/e354","DOI":"10.1542\/peds.112.5.e354"},{"key":"2021120822314703500_R18","unstructured":"Sangtawesin V, Sangtawesin C, Raksasinborisut C, et al. Oral ibuprofen prophylaxis for symptomatic patent ductus arteriosus of prematurity. J Med Assoc Thai.\u20082006;89(3):314\u2013321"},{"key":"2021120822314703500_R19","doi-asserted-by":"crossref","unstructured":"Raju NV, Bharadwaj RA, Thomas R, Konduri GG. Ibuprofen use to reduce the incidence and severity of bronchopulmonary dysplasia: a pilot study. J Perinatol.\u20082000;20(1):13\u201316","DOI":"10.1038\/sj.jp.7200296"},{"key":"2021120822314703500_R20","doi-asserted-by":"crossref","unstructured":"Sharma PK, Garg SK, Narang A. Pharmacokinetics of oral ibuprofen in premature infants. J Clin Pharmacol.\u20082003;43(9):968\u2013973","DOI":"10.1177\/0091270003254635"},{"key":"2021120822314703500_R21","doi-asserted-by":"crossref","unstructured":"Aranda JV, Varvarigou A, Beharry K, et al. Pharmacokinetics and protein binding of intravenous ibuprofen in the premature infant. Acta Paediatr.\u20081997;86(3):289\u2013293","DOI":"10.1111\/j.1651-2227.1997.tb08892.x"},{"key":"2021120822314703500_R22","doi-asserted-by":"crossref","unstructured":"Varvarigou A, Bardin CL, Beharry K, Chemtob S, Papageorgiou A, Aranda JV. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA.\u20081996;275(7):539\u2013544","DOI":"10.1001\/jama.275.7.539"},{"key":"2021120822314703500_R23","doi-asserted-by":"crossref","unstructured":"Desfrere L, Zohar S, Morville P, et al. Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method. J Clin Pharm Ther.\u20082005;30(2):121\u2013132","DOI":"10.1111\/j.1365-2710.2005.00630.x"},{"key":"2021120822314703500_R24","doi-asserted-by":"crossref","unstructured":"De Carolis MP, Romagnoli C, Polimeni V, et al. Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants. Eur J Pediatr.\u20082000;159(5):364\u2013368 (7)","DOI":"10.1007\/s004310051288"},{"key":"2021120822314703500_R25","doi-asserted-by":"crossref","unstructured":"Van Overmeire B, Allegaert K, Casaer A, et al. Prophylactic ibuprofen in premature infants: a multicentre, randomized, double blind, placebo-controlled trial. Lancet.\u20082004;364(9449):1945\u20131949","DOI":"10.1016\/S0140-6736(04)17477-1"},{"key":"2021120822314703500_R26","doi-asserted-by":"crossref","unstructured":"Gournay V, Roze JC, Kuster A, et al. Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial. Lancet.\u20082004;364(9449):1939\u20131344","DOI":"10.1016\/S0140-6736(04)17476-X"},{"key":"2021120822314703500_R27","doi-asserted-by":"crossref","unstructured":"Su PH, Chen JY, Su CM, Huang TC, Lee HS. Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Pediatr Int.\u20082003;45(6):665\u2013670","DOI":"10.1111\/j.1442-200X.2003.01797.x"},{"key":"2021120822314703500_R28","doi-asserted-by":"crossref","unstructured":"Patel J, Roberts I, Azzopardi D, Hamilton P, Edwards AD. Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res.\u20082000;47(1):36\u201342","DOI":"10.1203\/00006450-200001000-00009"},{"key":"2021120822314703500_R29","unstructured":"Tiker F, Yildirim SV. Acute renal impairment after oral ibuprofen for medical closure of patent ductus arteriosus. Indian Pediatr.\u20082007;44(1):54\u201355"},{"key":"2021120822314703500_R30","doi-asserted-by":"crossref","unstructured":"Tatli MM, Kumral A, Duman N, Demir K, Gurcu O, Ozkan H. Spontaneous intestinal perforation after oral ibuprofen treatment of patent ductus arteriosus in 2 very low birth weight infants. Acta Paediatr.\u20082004;93(7):999\u20131001","DOI":"10.1111\/j.1651-2227.2004.tb02702.x"},{"key":"2021120822314703500_R31","doi-asserted-by":"crossref","unstructured":"Pereira-da-Silva L, Pita A, Virella D, et al. Oral ibuprofen for patent ductus arteriosus closure in preterm infants: does high osmolality matter?Am J Perinatol.\u20082008;25(5):319\u2013320","DOI":"10.1055\/s-2008-1075035"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/122\/6\/e1256\/1032846\/zpe012080e1256.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/122\/6\/e1256\/1032846\/zpe012080e1256.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T21:15:32Z","timestamp":1684703732000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/122\/6\/e1256\/68797\/Randomized-Pilot-Study-Comparing-Oral-Ibuprofen"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,1]]},"references-count":31,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2008,12,1]]},"published-print":{"date-parts":[[2008,12,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2008-1780","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,1]]}}}